33996-33-7CC(=O)N1C[C@H](O)C[C@H]1C(=O)OBAPRUDZDYCKSOQ-RITPCOANSA-NOxaceprol is an L-proline derivative that is L-proline substituted by acetyl and hydroxy groups at positions 1 and 4R, respectively. It is an anti-inflammatory drug used for the management of osteoarthritis. It has a role as an anti-inflammatory drug and a dermatologic drug. It is a member of acetamides, a pyrrolidinemonocarboxylic acid, a monohydroxypyrrolidine and a L-proline derivative.
33996-33-7DTXSID2046410CHEMBL1407356CHEBI:233149Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H315 (11.8%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 51 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
D - Dermatologicals
M - Musculo-skeletal system
QD - Dermatologicals
QM - Musculo-skeletal system
Drugs used to treat or prevent skin disorders or for the routine care of skin.
Drugs that are used to treat RHEUMATOID ARTHRITIS.
Usestrans-1-Acetyl-4-hydroxy-L-proline can be used:In the stereospecific synthesis of 4-fluoroglutamic acid.To synthesize molecular targets for von Hippel-Lindau (VHL) E3 ubiquitin ligase.As a precursor to synthesize pseudopoly(amino acids) such as poly(trans-4-hydroxy-4-acyl-L-proline ester) and a biodegradable polymer, poly(lactic acid-glycolic acid-4-hydroxyproline).
Loading…